Pharma Journalist -

Sentynl Therapeutics, a U.S.-based biopharmaceutical company and a wholly owned subsidiary of Zydus Lifesciences, has entered into a licensing agreement with South Korea-based PRG…
Read More...

Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for the treatment of pediatric patients aged 12 years and older with moderate…
Read More...

GSK plc has announced that the U.S. Food and Drug Administration (FDA) has expanded the approved use of its respiratory syncytial virus (RSV) vaccine, Arexvy, to include adults aged 18…
Read More...

Akeso, Inc. has announced that its novel trispecific antibody candidate, AK150, has received Investigational New Drug (IND) clearance from the National Medical Products Administration…
Read More...

Earendil Labs has entered into a strategic collaboration with WuXi Biologics to accelerate the development and manufacturing of a portfolio of next-generation biologics, including…
Read More...

GelMEDIX Inc. and Catalent, Inc. have announced a global partnership aimed at advancing regenerative therapies designed to restore vision in patients with ocular and retinal diseases.…
Read More...

Johnson & Johnson has received approval from the U.S. Food and Drug Administration for its TECNIS PureSee intraocular lens (IOL), a new extended depth of focus (EDOF) lens designed…
Read More...

Vima Therapeutics has announced significant progress in the development of its experimental treatment for movement disorders, revealing that the first patient has been dosed in a Phase…
Read More...

PsiQuantum has announced a new collaborative research agreement with National Cancer Center Japan aimed at advancing the use of utility-scale quantum computing in oncology and…
Read More...

Eli Lilly and Company has issued a public warning about potential safety risks linked to compounded versions of tirzepatide that are being mixed with vitamin B12 and marketed to…
Read More...